August 2014

Celgene's successful cancer drugs Thalomid and Revlimid are at the center of an antitrust action. On April 3rd, Mylan…

The European Medicines Agency (EMA) Management Board has been inching towards a policy on clinical trial transparency.…

A recent article in Forbes argues that misplaced public distrust of the pharmaceutical industry could harm the research and…

"There is a striking absence of transparency and accountability in the GME financing system for producing the types of physicians…

New survey research from Ernst & Young (EY) finds that the majority of payers in the US and Europe believe that drug…

In December 2013, we noted that the government has been increasingly using the False Claims Act (FCA) to combat fraud.…

August 7, 2014; 3:58 PM: "The Open Payments system has been taken offline temporarily to investigate a reported issue," says the…

The American Academy of Family Physicians (AAFP) "strongly disagrees" with the Centers for Medicare and Medicaid…

A recent report by Cegedim Strategic Data (CSD), a leading provider of healthcare market research, examined 2013…

Medial associations and specialty societies have been understandably frustrated with the way the Physician Payments…